Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

37results about How to "Antitumor activity" patented technology

Glycolipid derivative

The present invention is a compound of general formula (I) or a pharmaceutically acceptable salt of,wherein W represents carbon chain from 9 to 17 which containing double bond or hydroxy group occasionally; X represents carbon chain from 11 to 25 which containing double bond or hydroxy group occasionally; Y represents -(CH2)a-CH=CH-(CH2)a'-, -(CH2)a- (a, a' denotes an integer of 0-5 and a+a' is 5 and under.), -S(O)0-2CH2-, -NHCH2-; Z represents -CO-, -SO2-; R represents -CH2OH, CO2H, CH2OCH2CO2SO3H; R0 represents -OH, -NH2, -NHAc.
Owner:KOTOBUKI PHARMA CO LTD

Quinoline or quinazoline derivatives inhibiting auto-phosphorylation of fibroblast growth factor receptors

An objective of the present invention is to provide novel compounds which have inhibitory activity against autophosphorylation of an FGF receptor family and, when orally or intraveneously administered, can suppress the growth of cancer cells. The compounds of the present invention are represented by formula (I) or a pharmaceutically acceptable salt or solvate thereof:wherein X represents CH or N; Z represents O or S; Q represents NR10, CR11R2, carbonyl, O, S(═O)m, wherein m is 0 to 2, or urea; R1 to R3 each independently represent H, OH, halogen, nitro, amino, alkyl, alkoxy or the like in which the alkyl and alkoxy groups are optionally substituted; R4 represents H; R5 to R8 each independently represent H, halogen, alkyl, or alkoxy; and R9 represents an optionally substituted carbocyclic or heterocyclic group.
Owner:KYOWA HAKKO KIRIN CO LTD

Novel glycolipid derivatives

The present invention is a compound of general formula (I) or a pharmaceutically acceptable salt of, wherein W represents carbon chain from 9 to 17 which containing double bond or hydroxy group occasionally; X represents carbon chain from 11 to 25 which containing double bond or hydroxy group occasionally; Y represents -(CH2)a-CH=CH-(CH2)a'-, -(CH2)a- (a, a' denotes an integer of 0-5 and a+a' is 5 and under.), -S(O)0-2CH2-, -NHCH2-; Z represents -CO-, -SO2-; R represents -CH2OH, CO2H, CH2OCH2CO2SO3H; R0 represents -OH, -NH2, -NHAc.
Owner:KOTOBUKI PHARMA CO LTD

Biosynthetic gene cluster for the maytansinoid antitumor agent ansamitocin

InactiveUS20060084141A1Potent antitumor activityReduced human toxicityOrganic active ingredientsFungiAnsamitocinsToxicity
The present invention relates to compositions and methods involving antitumor agents derived from bacteria. In particular, the present invention provides the ansamitocin biosynthetic gene cluster for the production of novel maytansinoid analogs with potent antitumor activity and reduced human toxicity.
Owner:UNIV OF WASHINGTON

Conjugation Product

A peptide which selectively inhibits αvβ3 integrin which comprises the deamidation product of a peptide comprising the NGR motif.
Owner:MOLMED SPA +1

Nanometer selenium hydrosol having antitumor activity, preparation method, preservation method and applications thereof

The present invention relates to the technical field of nanometer selenium hydrosols, particularly to a nanometer selenium hydrosol having antitumor activity, a preparation method, a preservation method and applications thereof, wherein the hydrosol at least contains nanometer selenium with a concentration of 0.5-5.0 mmol / L, and Coriolus versicolor polysaccharide protein with a concentration of 100.0-600.0 mg / L. The preparation method at least comprises: S01, adding a solution containing selenium ions and / or selenous ions to a Coriolus versicolor polysaccharide protein aqueous solution; S02, adding a reducing agent solution to the mixed solution obtained in the step S01 in a dropwise manner, and shaking; and S03, carrying out volume metering on the product obtained after the reducing reaction, and carrying out dialysis treatment. According to the present invention, the hydrosol is stable at a temperature of 2-10 DEG C; and the Coriolus versicolor polysaccharide protein has the hydrophilic hydroxyl and the hydrophilic amino, and the two groups can enhance the affinity between the nanometer selenium and the cancer cells, and can improve the uptake on the nanometer selenium by tumor cells so as to achieve the whole treatment effect of medication dosage reducing, treatment effect improving and less toxic-side effect, such that the effective scheme is provided for the combination chemotherapy of cancers in the clinic.
Owner:THE HONG KONG POLYTECHNIC UNIV SHENZHEN RES INST +2

Three spiral lentinan with anti-cancer activity and its preparation and use

This invention relates to three-spiral lentina with beta-(1-3)-D-glucan having 20-30%(1-6) chain connected glucose side chains as main chain. It shows three chains in water, with average molecular weight of 20,000-200,000. It is produced by: cutting dry shiitake, removing fat by Suo extraction, soaking in normal saline, centrifuging, extracting remains at 100-130 degrees C, centrifuging, extracting remains in water solution of NaOH / NaBH4, adding acetic acid into extracting liquid to neutralize, decoloring supernatant, removing free protein, dialyzing, concentrating, and frozen drying. It has higher anti-tumor activity and can be used to prepare medicines or health-care products for improving immune ability and antitumor.
Owner:WUHAN UNIV

Anti cd25 fc gamma receptor bispecific antibodies for tumor specific cell depletion

The present disclosure relates to a method of treating a solid tumour, wherein said method involves the use of an antibody to CD25. In particular, the antibody to CD25 is optimized for depletion of regulatory T cells (Treg) within tumours. The present invention also provides novel anti-CD25 antibodies and their combination with other anti-cancer drugs, such as immune checkpoint inhibitors, compounds that target cancer antigens or the inhibitory Fc receptor FcyR11b (CD32b).
Owner:CANCER RES TECH LTD

Panax japonicus polysaccharides, preparation method and use thereof

The invention discloses panax japonicus polysaccharide. The main chain structure thereof is Beta-1 to 4-D glucan and heterosaccharide containing mannan, galactan and xylan branched chain, the weight-average molecular weight of the panax japonicus polysaccharide is 5,000 to 200,000, the intrinsic viscosity at 25 DEG C is 1 to 50ml / g, and the mole ratio of the three elements of C: H: O is 1: 2: 1. The method for preparing the panax japonicus polysaccharide comprises the following steps: after being dried, smashed and skimmed, the panax japonicus is extracted by neutral salt water solution or pure water, and the white panax japonicus polysaccharide which can be easily dissolved in water, be dissolved in DMSO and not be dissolved in methanol, ethanol and acetone is obtained by separation, saponin removal, decolorization, dehydration, protein removal, desalination and drying. The panax japonicus polysaccharide which is prepared by the invention has higher anti-tumor activity and promotion of immune activity, which can be used for preparing drugs or health care products for improving immune function and anti-tumor. The method for preparing the product is simple and easy to operation, and the sources of the needed raw materials are wide.
Owner:WUHAN UNIV

C10-substituted camptothecin analogs

InactiveUS20090099166A1Highly lipophilicSubstantial lactone stabilitySilicon organic compoundsBiocidePharmacologyGlucuronidation
The novel C10-modified camptothecin analogs, and pharmaceutically-acceptable salts thereof, of the present invention: (i) possess potent antitumor activity (i.e., in nanomolar or subnanomolar concentrations) for inhibiting the growth of human and animal tumor cells in vitro; (ii) are potent inhibition of Topoisomerase I; (iii) lack of susceptibility to MDR / MRP drug resistance; (iv) require no metabolic drug activation: (v) lack glucuronidation of the A-ring or B-ring; (vi) reduce drug-binding affinity to plasma proteins; (vii) maintain lactone stability; (viii) maintain drug potency; and (ix) possess a low molecular weight (e.g., MW<600).
Owner:CROWN BIOSCIENCE INC

Modified cytokines for use in cancer therapy

Cytokine derivatives capable of homing the tumoral vessels and the antigen presenting cells and the use thereof as antitumoral agents.
Owner:OSPEDALE SAN RAFFAELE SRL

Lanthanum amino acid complex and its preparing process and application

The invention relates to Lanthanum amino acid complex and its preparing process and application, wherein the complex has the chemical name of which has the chemical name of 10-phenanthroline-2-methylene}-alpha-phenylalanine lanthanum (III) complex, which has the structural formula disclosed in the specification, and is prepared by reacting 1,10-phenanthroline-2-formaldehyde with alpha-phenylalanine, reducing with NaBH4, coordinating with lanthanum (III), thus obtaining single core complex, then reacting the single core complex with terephthalic acid. The obtained compound can be used for cancer resistance, which has better anti-cancer activity and wide spectrum.
Owner:NANKAI UNIV

Genistein derivative as well as preparation method and application thereof in pharmacy

The invention belongs to the field of medical technology and discloses a genistein derivative with a structure shown by formula I in the specification or a pharmaceutically acceptable salt thereof. The invention also discloses an application of the genistein derivative or the pharmaceutically acceptable salt thereof in preparing a tumor treating medicine, an application in preparing an inflammation-related tumor treating medicine and an application in preparing a medicine inhibiting tumor cell invasion and migration. The genistein derivative disclosed by the invention generates a growth inhibiting and killing effect on tumor cells to realize an anti-tumor effect and has broad-spectrum anti-tumor activity while the effect is relatively good; the genistein derivative promises a perfect treatment effect on the AOM / DSS induced inflammation related tumor; and with relatively good ability of inhibiting tumor cell invasion and migration, the genistein derivative can be used for preparing a medicine inhibiting tumor migration and can be made into tumor migration inhibiting medicines of various dosage forms, thereby providing a better choice for tumor patients.
Owner:CHINA PHARM UNIV

Panax japonicus polysaccharides, preparation method and use thereof

The invention discloses panax japonicus polysaccharide. The main chain structure thereof is Beta-1 to 4-D glucan and heterosaccharide containing mannan, galactan and xylan branched chain, the weight-average molecular weight of the panax japonicus polysaccharide is 5,000 to 200,000, the intrinsic viscosity at 25 DEG C is 1 to 50ml / g, and the mole ratio of the three elements of C: H: O is 1: 2: 1. The method for preparing the panax japonicus polysaccharide comprises the following steps: after being dried, smashed and skimmed, the panax japonicus is extracted by neutral salt water solution or pure water, and the white panax japonicus polysaccharide which can be easily dissolved in water, be dissolved in DMSO and not be dissolved in methanol, ethanol and acetone is obtained by separation, saponin removal, decolorization, dehydration, protein removal, desalination and drying. The panax japonicus polysaccharide which is prepared by the invention has higher anti-tumor activity and promotion of immune activity, which can be used for preparing drugs or health care products for improving immune function and anti-tumor. The method for preparing the product is simple and easy to operation, and the sources of the needed raw materials are wide.
Owner:WUHAN UNIV

Panax japonicus polysaccharides, preparation method and use thereof

The invention discloses panax japonicus polysaccharide.The main chain structure thereof is Beta-D-1 to 3-mannan and / or Alpha-D-3 to 4-mannan and heterosaccharide containing galactan, xylan and glucan, the weight-average molecular weight of the panax japonicus polysaccharide is 5,000 to 2,000,000, the intrinsic viscosity at 25 DEG C is 1 to 100ml / g, and the mole ratio of the three elements of C: H: O is 1: 2: 1. The preparation of the panax japonicus polysaccharide comprises the following steps: after being dried, smashed and skimmed, the panax japonicus is soaked by water under the normal temperature and is stirred for separation, the residue is extracted by high-pressure hot water, further extracted by alkali and reductive salt, and finally extracted by acid, and the panax japonicus polysaccharide which can be dissolved in water and DMSO and not be dissolved in methanol, ethanol and acetone is obtained by separation, neutralization by taking the solution, dehydration, protein removal, decolorization, desalination and drying. The panax japonicus polysaccharide which is prepared by the invention has higher anti-tumor activity and promotion of immune activity, which can be used for preparing drugs or health care products for improving immune function and anti-tumor. The method for preparing the product is simple and easy to operation, and the sources of the needed raw materials are wide.
Owner:WUHAN UNIV

Sauced crisp oxtongue and preparation method thereof

The invention discloses sauced crisp oxtongue and a preparation method thereof. The sauced crisp oxtongue is prepared from the following raw materials: 100kg of oxtongues, 5-10g of ham spice, 80-120g of baking soda, 45-60g of white pepper powder, 800-1000g of monosodium glutamate, 80-110g of white granulated sugar, 150-160g of Baomeilin, 50-80g of sodium diacetate, 1000-1200g of edible salt, 0.2-0.5kg of soyabean protein, 0.8-1kg of modified starch, 5-8kg of soy sauce, 165-180g of sterculia nobilis extract and 4-6kg of water. The prepared sauced crisp oxtongue is unique in flavor and thick in aftertaste, and the sterculia nobilis extract is added, so that the effects of resisting to arrhythmia, resisting to tumor activity, inhibiting inflammation and stopping pain, lowering cholesterol, regulating endocrine glands and balancing hormone can be realized. Besides, technology is simple, operation is easy, and the sauced crisp oxtongue is applicable to large-scale production.
Owner:PUTIAN CHENGXIANG DISTRICT CHENGWEI FOOD CO LTD

Nano-selenium hydrosol with anti-tumor activity, preparation, preservation method and application

The invention relates to the technical field of nano-selenium hydrosol, in particular to a nano-selenium hydrosol with anti-tumor activity and its preparation, preservation method and application. The hydrosol at least contains components with the following concentrations: 0.5mmol / L-5.0mmol / L of nano-selenium; 100.0mg / L-600.0mg / L of versicolor polysaccharide protein. The preparation method of the hydrosol at least includes step S01. adding a solution containing selenium ions and / or selenium ions to the polysaccharide protein aqueous solution of versicolor versicolor; step S02. adding a reducing agent solution dropwise to the mixed solution obtained in step S01, and shaking; Step S03. The product obtained from the reduction reaction in step S02 is subjected to constant volume and dialysis treatment. The hydrosol exists stably at 2-10°C. Because the polysaccharide protein of Yunzhi polysaccharide has hydrophilic hydroxyl and amino groups, these two groups can enhance the affinity between nano-selenium and cancer cells, increase the uptake of nano-selenium by tumor cells, and then reduce the dosage of drugs and increase the curative effect The overall therapeutic effect with less toxic and side effects provides a more effective solution for clinical combination chemotherapy of cancer.
Owner:THE HONG KONG POLYTECHNIC UNIV SHENZHEN RES INST +2

Compound polysaccharide oral liquid with anti-oxidization and anti-tumor activity and preparation and application thereof

The invention belongs to the technical field of healthcare, and discloses compound polysaccharide oral liquid with anti-oxidization and anti-tumor activity and preparation and application thereof. The compound polysaccharide oral liquid is composed of compound polysaccharides, a sweetening agent, an acid agent, a preservative and water. The compound polysaccharides are prepared from, by weight, 10-30 parts of shii-take, 10-30 parts of tremella, 10-30 parts of fructus lycii and 10-30 parts of radix astragali. The compound polysaccharide oral liquid is high in purity and good in function, has a remarkable anti-oxidization effect and anti-tumor activity and is simple in preparation method.
Owner:SOUTH CHINA UNIV OF TECH

Imidazole [4,5-c] pyridine-7-methanamide derivative as well as preparation method and medical application thereof

The invention relates to the field of medicinal chemistry and in particular relates to an imidazole [4,5-c] pyridine-7-methanamide derivative (I), wherein R is defined in the specification. Pharmacodynamic tests proof that the derivative compound provided by the invention can serve as a tumour therapeutic agent and especially the derivative compound has extremely strong anti-tumour effect when being combined with cis-platinum. The invention also discloses a preparation method of the derivative compound and a pharmaceutical composition comprising the derivative compound.
Owner:HEFEI IND PHARMA INST +1

Polymer Conjugate Of Hexa-Coordinated Platinum Complex

A DDS preparation of a platinum complex, which selectively releases a highly active platinum complex in cells that are under reducing conditions, and exhibits high antitumor activity that is required from a medicine, is still not available, and there is a demand for a novel DDS preparation of a platinum complex that may be used in clinical fields. There is provided a polymer conjugate of a hexa-coordinated platinum complex, the polymer conjugate comprising a block copolymer having a polyethylene glycol structural moiety and a polyaspartic acid moiety or a polyglutamic acid moiety; and a hexa-coordinated platinum complex having a halogen atom and a hydroxyl group at the axial positions, the hexa-coordinated platinum complex being bonded, directly or via a spacer, to a side-chain carboxyl group of the block copolymer.
Owner:NIPPON KAYAKU CO LTD

Extraction method for plane tree bark polysaccharide

The invention provides an extraction method for plane tree bark polysaccharide. Plane tree bark medicinal material residues after processing of organic solvents and extraction of components of betulinic acid and the like are employed for extraction of polysaccharide components. The method comprises the following steps: first, the medicinal material residues are dried in the sun, soaked in cold water for overnight, and the liquid level exceeds the medicinal material residues; second, filtration is carried out, the filtrate is collected, the filter residues are heated and soaked in warm water with a temperature of 50-60 DEG C twice, each time is for 3-6h, and the three filtrates are mixed; third, the mixed filtrate obtained from the second step is subjected to pressure reduction concentration until a slurry is formed, 95% of ethanol is added until the content of ethanol in the concentrated solution is 78%-82%, and the mixture is permitted to stand for above 8h; fourth, pumping filtration is carried out, the filter residues are washed with acetone for three times, and dried, and the polysaccharide is obtained. The method makes good use of waste materials of plane tree barks after extraction of betulinic acid, and polysaccharide components with strong antineoplastic activity are extracted. The method is suitable for production and has low cost.
Owner:CHIFCON DRUG DISCOVERY SUZHOU

Preparation method for two novel compounds with antitumor activity extracted from isodon excisoides and application of two novel compounds

The invention relates to a preparation method for two novel compounds with antitumor activity extracted from isodon excisoides and an application of the two novel compounds. The novel compounds are extracted from the isodon excisoides and are applied to the preparation of antitumor drugs. The method comprises the steps: adding water into the isodon excisoides, carrying out boiling extraction, introducing an extract sample to a macroporous adsorption resin column, and carrying out gradient elution by using water and ethanol, so as to obtain Fr. A, Fr. B, Fr. C and Fr. D; subjecting part of Fr. C to gel column chromatography and methanol-water gradient elution, so as to obtain Fr. C1, Fr. C2, Fr. C3 and Fr. C4; and subjecting part of Fr. C2 to silica-gel column chromatography and petroleum ether-acetone and methanol gradient elution, so as to obtain Fr. B1-1, Fr. B1-2, Fr. C2a, Fr. C2b, Fr. C2c and Fr. C2d, subjecting Fr. C2c to methanol recrystallization so as to obtain an acetonitrile-water for white powder as eluate, carrying out semipreparative HPLC purification, collecting chromatographic peaks at 56.4min and 61.2min, separately placing products in a solvent, and carrying out anhydrous sodium sulfate dehydrating and nitrogen gas drying-up, thereby obtaining a compound 1 and a compound 2. The preparation method provided by the invention is easy in operation, high in orienting property, high in separating rate, high in efficiency and high in product purity and can be effectively used for preparing the antitumor drugs.
Owner:HENAN UNIV OF CHINESE MEDICINE

Immunotherapy for the treatment of cancer

The present invention relates to a kit-of-parts comprising and a composition comprising a polyplex comprising a double stranded RNA (dsRNA) and a polymeric conjugate comprising a polyethyleneimine (PEI), one or more polyethylene glycol (PEG) moieties and one or more targeting moieties, and wherein each of said one or more targeting moieties is capable of binding to a cancer antigen; and at least one antibody, wherein said at least one antibody is capable of modulating an immune checkpoint protein. Further the invention relates to this composition or kit-of-parts for use in the treatment of cancer.
Owner:TARGIMMUNE THERAPEUTICS AG

Polymer conjugate of sulfoxide derivative-coordinated platinum(II) complex

A DDS preparation of a platinum complex, which exhibits a superior antitumor effect required as a medicine and reduced side effects, that is, a clinically usable DDS preparation of a platinum complex, which is conjugated to a polymer carrier that is different from conventional carriers, is desired.Provided is a polymer conjugate of a platinum(II) complex, the polymer conjugate including: a block copolymer having a polyethylene glycol structural moiety and a polyaspartic acid moiety or a polyglutamic acid moiety; a sulfoxide derivative introduced into a side-chain carboxyl group of the block copolymer; and a platinum(II) complex coordinate-bonded to a sulfoxide group of the sulfoxide derivative.
Owner:NIPPON KAYAKU CO LTD

Imidazol[4,5-c]pyridine-7-carboxamide derivative, its preparation method and medical application

The invention relates to the field of medicinal chemistry and in particular relates to an imidazole [4,5-c] pyridine-7-methanamide derivative (I), wherein R is defined in the specification. Pharmacodynamic tests proof that the derivative compound provided by the invention can serve as a tumour therapeutic agent and especially the derivative compound has extremely strong anti-tumour effect when being combined with cis-platinum. The invention also discloses a preparation method of the derivative compound and a pharmaceutical composition comprising the derivative compound.
Owner:HEFEI IND PHARMA INST CO LTD +1

Blood group A epitope mimic peptide and application thereof

The invention provides a blood group A epitope mimic peptide. The amino acid sequence of the peptide is Tyr-Val-Asp-Ser-Lys-Ala-Phe-Arg-Ala-Val-Val-Arg. The blood group A epitope mimic peptide can mimic carbohydrate epitope of blood group A and is used for preparing anti-tumor DNA vaccines. The invention also provides the anti-tumor DNA vaccines which are constructed by inserting the genes codingthe peptide according to the claim 1 and the fusion protein with intracellular domain of Fas into the multiple clone sites of the pIRES plasmids. After being injected into part of the tumor, the DNA vaccines can be absorbed by the tumor cells and express the mimic peptide and the fusion protein of the anti-tumor factors so that the mimic peptide is bonded with the complement and the naturally existing antibody to give play to CDC and ADCC to kill the tumor cells.
Owner:SOUTHERN MEDICAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products